Clinical Diagnostics News and Research

RSS

Ortho-Clinical Diagnostics announces availability of NEPHROCHECK Test System for AKI patients

Ortho-Clinical Diagnostics, Inc. today announced the nationwide availability to hospitals of the NEPHROCHECK Test System designed to help healthcare providers identify patients at risk of developing moderate or severe acute kidney injury (AKI) within 12 hours of patient assessment.

From Ortho-Clinical Diagnostics, Inc. 16 Dec 2014

Researchers test new nanopore DNA sequencing technology to detect cause of antibiotic resistance

New nanopore DNA sequencing technology on a device the size of a USB stick could be used to diagnose infection - according to new research from the University of East Anglia and Public Health England.

From Oxford Nanopore Technologies 9 Dec 2014

OCD's ORTHO VISION Analyzer gets CE Mark approval for improved safety of blood transfusions

Ortho-Clinical Diagnostics, Inc. today announced that it obtained CE Mark (Conformité Européenne) for the ORTHO VISION Analyzer, a highly interactive, fully automated analyzer for transfusion medicine laboratories.

From Ortho-Clinical Diagnostics, Inc. 29 Oct 2014

Johnson & Johnson's sales increase 5.1% to $18.5 billion in Q3 2014

Johnson & Johnson today announced sales of $18.5 billion for the third quarter of 2014, an increase of 5.1% as compared to the third quarter of 2013. Operational results increased 5.8% and the negative impact of currency was 0.7%. Domestic sales increased 11.6%. International sales decreased 0.3%, reflecting operational growth of 1.0% and a negative currency impact of 1.3%.

14 Oct 2014

Astute Medical to get $30 million from CRG to support commercialization of NephroCheck Test System

Astute Medical, Inc. and CRG today announced that Astute recently achieved a milestone under the terms of its existing term loan agreement with CRG. Under the term loan agreement, CRG will provide up to $30 million to support the commercialization of the NephroCheck Test System.

9 Oct 2014

NCI awards $1.4M grant to Advanced Cell Diagnostics to develop diagnostic test for B-cell NHLs

Advanced Cell Diagnostics, Inc. (ACD), a global technology and market leader in in situ nucleic acid detection for life science research and clinical diagnostics, has been awarded a two-year, $1.4 million grant from National Cancer Institute (NCI) under its SBIR Phase II Program.

From Advanced Cell Diagnostics 7 Oct 2014

NanoString, BWH partner to translate genomic biomarker discoveries into clinical cancer diagnostics

NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that it has signed a multi-year, multi-investigator research collaboration with Harvard-affiliated Brigham and Women's Hospital to accelerate the translation of genomic biomarker discoveries into clinical cancer diagnostics.

From NanoString Technologies 7 Oct 2014

AIT, BioVendor and SCIENION partner to develop in-vitro diagnostic test for colon cancer

The AIT Austrian Institute of Technology, BioVendor and SCIENION today announced that the three companies will partner on the development of an in-vitro diagnostic test for colon cancer. The innovative test kit shall identify cancer at an early stage based on tumor autoantibody biomarkers.

24 Sep 2014

ISO 13485:2003 certification for Advanced Cell Diagnostics

Advanced Cell Diagnostics, Inc. (ACD), a global technology and market leader in in situ nucleic acid detection for life science research and clinical diagnostics, has been granted ISO 13485:2003 certification, an international quality standard for medical devices, paving a path for ACD to launch its CE marked diagnostic tests in Europe.

From Advanced Cell Diagnostics 11 Aug 2014

Astute Medical, OCD partner to expand access to new acute kidney injury test

Astute Medical, Inc. today announced a strategic collaboration with Ortho-Clinical Diagnostics, Inc. that will expand access to a new test that assesses critically ill patients for risk of acute kidney injury (AKI), a prevalent and deadly condition.

From Ortho-Clinical Diagnostics, Inc. 28 Jul 2014

Beckman ranks among industry's highest performing Service providers in clinical diagnostics

Committed to providing the solutions labs need to meet the challenges they face, Beckman Coulter Diagnostics has been ranked among the industry's highest performing Service providers in the clinical diagnostics industry in the 2014 IMV ServiceTrak Executive Summary Report.

26 Jul 2014

Tackling hepatitis C: an interview with Gaston Picchio, Global Hepatitis Disease Area Leader at Janssen

Gaston Picchio outlines the major findings of the recent report published by The Economist Intelligence Unit (EIU): ‘Tackling hepatitis C: Moving towards an integrated policy approach’

23 Jul 2014

Johnson & Johnson sales increase 9.1% to $19.5 billion in second quarter 2014

Johnson & Johnson today announced sales of $19.5 billion for the second quarter of 2014, an increase of 9.1% as compared to the second quarter of 2013. Operational results increased 9.4% and the negative impact of currency was 0.3%.

15 Jul 2014

NMR Spectroscopy for In-Vitro Diagnostic Research

An interview with Dr. Manfred Spraul, discussing AVANCE, an advanced NMR spectrometer that is being applied to the fields of epidemiology and metabolomics.

From Bruker BioSpin - NMR, EPR and Imaging 2 Jul 2014

Electroanalysis journal publishes a special issue about clinical diagnostics

The demand for the development of novel diagnostic tools with interest for clinical analysis is increasing.

19 Jun 2014

Electroanalysis journal publishes a special issue about clinical diagnostics

The demand for the development of novel diagnostic tools with interest for clinical analysis is increasing.

19 Jun 2014

Agena Bioscience acquires Sequenom’s Bioscience business

Agena Bioscience, Inc., a portfolio company of Telegraph Hill Partners (THP), today acquired the Bioscience business of Sequenom, Inc., which sells the MassARRAY® System for mass spectrometry-based detection of nucleic acids in research and clinical laboratories.

31 May 2014

Bioengineers develop tool that reacts to chemical changes caused by cancer cells

Bioengineers at the University of Rome Tor Vergata and the University of Montreal have used DNA to develop a tool that detects and reacts to chemical changes caused by cancer cells and that may one day be used to deliver drugs to tumor cells.

8 May 2014

Johnson & Johnson's sales increase 3.5% to $18.1 billion in first quarter 2014

Johnson & Johnson today announced sales of $18.1 billion for the first quarter of 2014, an increase of 3.5% as compared to the first quarter of 2013. Operational results increased 5.3% and the negative impact of currency was 1.8%. Domestic sales increased 2.2%. International sales increased 4.5%, reflecting operational growth of 7.9% and a negative currency impact of 3.4%.

15 Apr 2014

Singulex signs agreement to co-develop the Sgx Clarity system with Tecan

Singulex, Inc., the developer and leading provider of Single Molecule Counting (SMC) technology for clinical diagnostics and scientific discovery, today announced an agreement to co-develop the Sgx Clarity system with Tecan, a leading global provider of laboratory automation instruments.

From Tecan 25 Mar 2014

Clinical Diagnostics News and Research

Ortho-Clinical Diagnostics announces availability of NEPHROCHECK Test System for AKI patients

Researchers test new nanopore DNA sequencing technology to detect cause of antibiotic resistance

OCD's ORTHO VISION Analyzer gets CE Mark approval for improved safety of blood transfusions

Johnson & Johnson's sales increase 5.1% to $18.5 billion in Q3 2014

Astute Medical to get $30 million from CRG to support commercialization of NephroCheck Test System

NCI awards $1.4M grant to Advanced Cell Diagnostics to develop diagnostic test for B-cell NHLs

NanoString, BWH partner to translate genomic biomarker discoveries into clinical cancer diagnostics

AIT, BioVendor and SCIENION partner to develop in-vitro diagnostic test for colon cancer

ISO 13485:2003 certification for Advanced Cell Diagnostics

Astute Medical, OCD partner to expand access to new acute kidney injury test

Beckman ranks among industry's highest performing Service providers in clinical diagnostics

Tackling hepatitis C: an interview with Gaston Picchio, Global Hepatitis Disease Area Leader at Janssen

Johnson & Johnson sales increase 9.1% to $19.5 billion in second quarter 2014

NMR Spectroscopy for In-Vitro Diagnostic Research

Electroanalysis journal publishes a special issue about clinical diagnostics

Electroanalysis journal publishes a special issue about clinical diagnostics

Agena Bioscience acquires Sequenom’s Bioscience business

Bioengineers develop tool that reacts to chemical changes caused by cancer cells

Johnson & Johnson's sales increase 3.5% to $18.1 billion in first quarter 2014

Singulex signs agreement to co-develop the Sgx Clarity system with Tecan

E-Cigarettes and Ethanol: A forensic Perspective on Vaping

Understanding Consumer-Consented Data to Optimize Digital Health Programs

The Future is Wearable: Advancing Human Health Through Portable Spectroscopy

Latest News